As of Sep 23
| +0.21 / +5.85%|
The 2 analysts offering 12-month price forecasts for BioTime Inc have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +97.37% increase from the last price of 3.80.
The current consensus among 2 polled investment analysts is to Buy stock in BioTime Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.